Search for Stocks Search for IPO Search for Indices

Customer Portal

EMI Card

Download

Offers

BAJAJ FINSERV DIRECT LIMITED

Open Your FREE Demat Account Now!

Apply Now

Fundamentals Financials Shareholding About Company Peer Comparison Latest News FAQs

Medicamen Organics Ltd. Share Price

NSE

BSE

NSE : MEDIORG

BSE : 0

Sector : Healthcare

N/A

indicator

1D

1M

3M

6M

1Y

5Y

Price Summary

Previous Close	₹20.00
Day's Range	₹20.00 - ₹20.30
Open	₹20.30
52 Week Range	₹19.50 - ₹49.70
Volume	6,000
Market Cap	₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs)	1.20
Market Cap (₹ in Mn)	0.00
Dividend Yield(%)	0.00
Price/Earning (TTM)	0.00
TTM EPS (₹)	-3.30
P/E Ratio	6.27
Book Value(₹)	0.79
PAT Margin (%)	10.60
Face Value (₹)	10.00
ROCE(%)	16.97

Financials

Particulars	QTR FY (₹ in Millions)	Annual FY (₹ in Millions)
Net sales	N/A	370.88
Expenses	N/A	N/A
PBT	N/A	43.87
Operating profit	N/A	0.0
Net profit	N/A	32.71

Shareholding Pattern

Promoters (% Holding)

59.73%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

38.56%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.07%

About Medicamen Organics Ltd.

Founded	1995
Managing Director	Bal Kishan Gupta
NSE Symbol	MEDIORG

Peer Comparision

Stocks Name	Market Cap (Cr)(₹)	Market Price (₹)	52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd.	4,29,145.05	1,780.50	1,548.00 - 1,548.00
Divi's Laboratories Ltd.	1,72,988.62	6,758.00	5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd.	1,49,322.13	4,466.30	3,140.10 - 3,140.10
Apollo Hospitals Enterprise Ltd.	1,20,125.61	8,525.60	6,696.50 - 6,696.50
Cipla Ltd.	1,12,149.13	1,376.75	1,165.70 - 1,165.70
Zydus Lifesciences Ltd.	1,09,422.92	1,106.10	835.50 - 835.50
Dr. Reddy's Laboratories Ltd.	1,06,482.91	1,268.75	1,148.40 - 1,148.40
Lupin Ltd.	1,02,996.20	2,257.00	1,836.80 - 1,836.80
Max Healthcare Institute Ltd.	97,913.19	1,003.25	903.00 - 903.00
Mankind Pharma Ltd.	97,382.57	2,390.00	1,909.70 - 1,909.70

Latest News

Jun

9

2026

EQUITY Posted on Jun 9^th 2026

Anlon Healthcare informs about conference call

Anlon Healthcare has informed that the transcript of the Earnings Conference call held on Wednesday, June 03, 2026 at 04:00 PM (IST) is attached. This will also be hosted on the Company’s website at https://www.anlon.in/reports.php?subid=15&name=Investor-Meet.

The above information is a part of company’s filings submitted to BSE.

Read More

Jun

9

2026

EQUITY Posted on Jun 9^th 2026

Ipca Laboratories informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has enclosed copies of the Newspaper Notice (Business Standard & Navshakti), issued to the shareholders of the Company in respect of transfer of equity shares to the IEPF Authority in accordance with the requirements of Section 124(6) of the Companies Act, 2013 read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.

The above information is a part of company’s filings submitted to BSE.

Read More

Jun

9

2026

EQUITY Posted on Jun 9^th 2026

Kerala Ayurveda informs about change in management

Kerala Ayurveda has informed that Samir Dhawan (DIN: 01178691), an Independent Director of the Company had resigned from the Board of the Company with effect from the close of business hours of June 09, 2026 vide his resignation letter dated June 09, 2026. In compliance with Regulation 30 read with Clause 7B of Para A of Part A of Schedule III of the SEBI Listing Regulations and SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed as ‘Annexure-A’. The resignation letter confirming that there are no other material reasons for his resignation is enclosed as ‘Annexure B’. The same is also being made available on the Company’s website at: https://keralaayurveda.com/pages/investors.

The above information is a part of company’s filings submitted to BSE.

Read More

Jun

9

2026

EQUITY Posted on Jun 9^th 2026

Makers Laboratories informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Makers Laboratories has enclosed notice published in the Newspaper (published in Business Standard and Navshakti), issued to the shareholders of the Company in respect of transfer of equity shares to the IEPF Authority in accordance with the requirements of Section 124(6) of the Companies Act, 2013 read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.

The above information is a part of company’s filings submitted to BSE.

Read More

Jun

9

2026

EQUITY Posted on Jun 9^th 2026

Vijaya Diagnostic Centre informs about investors meet

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vijaya Diagnostic Centre has informed that the officials of the Company will be interacting with Institutional Investors/ Analysts in Emkay Global Financial Services (Non-Deal Roadshow) on Monday, June 15, 2026 & Tuesday, June 16, 2026 from 09:00 am to 06:00 pm (IST) in Singapore (One on One Meeting – In Person). The above information is also available on the website of the Company: https://www.vijayadiagnostic.com/investors/disclosure-of-events.

The above information is a part of company’s filings submitted to BSE.

Read More

Sign in to Unlock Offers!

STEP 1/2

Open Demat Account today!

Mobile Number

Enter mobile number

Frequently Asked Questions

What is the current share price of Medicamen Organics Ltd. ?

The current share price of Medicamen Organics Ltd. is ₹20.00 as of 2026-06-09.

What is the Market Cap of Medicamen Organics Ltd. Share?

The market capitalisation of Medicamen Organics Ltd. is ₹25.55 as of 2026-06-05.

What is a 1 year return for Medicamen Organics Ltd. ?

The 1-year return of Medicamen Organics Ltd. is -1.00% as of 2026-06-09.

What is the P/E Ratio of Medicamen Organics Ltd. Share?

The P/E ratio of Medicamen Organics Ltd. is 6.27 as of 2026-06-09.

What is the 52 Week High and Low of Medicamen Organics Ltd. ?

The 52-week high and low of Medicamen Organics Ltd. are ₹49.70 and ₹19.50, respectively, as of 2026-06-09.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.

STEP 1/2

Open a Demat Account today!

Mobile Number Enter Valid Mobile Number

Indices : Nifty 50 Nifty Bank Nifty Financial Services Nifty Next 50 Nifty Midcap 100 BSE Sensex India Vix

Stocks : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Home

Shopping

Loan Offers

My Accounts

Explore